These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 19470245)
21. Jun activation domain-binding protein 1 is required for mitotic checkpoint activation via its involvement in hyperphosphorylation of 53BP1. Kwak HJ; Kim SH; Yoo HG; Park SH; Lee CH J Cancer Res Clin Oncol; 2005 Dec; 131(12):789-96. PubMed ID: 16187115 [TBL] [Abstract][Full Text] [Related]
22. Jab1/CSN5 induces the cytoplasmic localization and degradation of RUNX3. Kim JH; Choi JK; Cinghu S; Jang JW; Lee YS; Li YH; Goh YM; Chi XZ; Lee KS; Wee H; Bae SC J Cell Biochem; 2009 Jun; 107(3):557-65. PubMed ID: 19350572 [TBL] [Abstract][Full Text] [Related]
23. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells. Hsu MC; Chang HC; Hung WC Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096 [TBL] [Abstract][Full Text] [Related]
24. Physical interaction of Jab1 with human serotonin 6 G-protein-coupled receptor and their possible roles in cell survival. Yun HM; Baik JH; Kang I; Jin C; Rhim H J Biol Chem; 2010 Mar; 285(13):10016-10029. PubMed ID: 20093369 [TBL] [Abstract][Full Text] [Related]
25. Jab1 interacts directly with HIF-1alpha and regulates its stability. Bae MK; Ahn MY; Jeong JW; Bae MH; Lee YM; Bae SK; Park JW; Kim KR; Kim KW J Biol Chem; 2002 Jan; 277(1):9-12. PubMed ID: 11707426 [TBL] [Abstract][Full Text] [Related]
27. Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development. Panattoni M; Sanvito F; Basso V; Doglioni C; Casorati G; Montini E; Bender JR; Mondino A; Pardi R J Exp Med; 2008 Feb; 205(2):465-77. PubMed ID: 18268034 [TBL] [Abstract][Full Text] [Related]
28. Roles for CSN5 in control of p53/MDM2 activities. Zhang XC; Chen J; Su CH; Yang HY; Lee MH J Cell Biochem; 2008 Mar; 103(4):1219-30. PubMed ID: 17879958 [TBL] [Abstract][Full Text] [Related]
29. Jun activation domain-binding protein 1 negatively regulate p27 kip1 in non-Hodgkin's lymphomas. Wang Y; Fei M; Cheng C; Zhang D; Lu J; He S; Zhao Y; Wang Y; Shen A Cancer Biol Ther; 2008 Mar; 7(3):460-7. PubMed ID: 18285702 [TBL] [Abstract][Full Text] [Related]
30. JAB1 regulates CPNE1-related differentiation via direct binding to CPNE1 in HiB5 hippocampal progenitor cells. Yoo JC; Park N; Choi HY; Park JY; Yi GS Biochem Biophys Res Commun; 2018 Feb; 497(1):424-429. PubMed ID: 29448099 [TBL] [Abstract][Full Text] [Related]
31. Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma. Wang Y; Wang Y; Cheng C; Ji Y; Zhao Y; Zou L; Shen A J Cancer Res Clin Oncol; 2009 Jul; 135(7):951-9. PubMed ID: 19139918 [TBL] [Abstract][Full Text] [Related]
32. Jab1, a novel protease-activated receptor-2 (PAR-2)-interacting protein, is involved in PAR-2-induced activation of activator protein-1. Luo W; Wang Y; Hanck T; Stricker R; Reiser G J Biol Chem; 2006 Mar; 281(12):7927-36. PubMed ID: 16410250 [TBL] [Abstract][Full Text] [Related]
33. Hypoxia-inducible factor 1 promoter-induced JAB1 overexpression enhances chemotherapeutic sensitivity of lung cancer cell line A549 in an anoxic environment. Hu MD; Xu JC; Fan Y; Xie QC; Li Q; Zhou CX; Mao M; Yang Y Asian Pac J Cancer Prev; 2012; 13(5):2115-20. PubMed ID: 22901179 [TBL] [Abstract][Full Text] [Related]
34. Zinc-dependent interaction between JAB1 and pre-S2 mutant large surface antigen of hepatitis B virus and its implications for viral hepatocarcinogenesis. Hsu JL; Chuang WJ; Su IJ; Gui WJ; Chang YY; Lee YP; Ai YL; Chuang DT; Huang W J Virol; 2013 Dec; 87(23):12675-84. PubMed ID: 24049181 [TBL] [Abstract][Full Text] [Related]
35. The pivotal oncogenic role of Jab1/CSN5 and its therapeutic implications in human cancer. Guo Z; Wang Y; Zhao Y; Shu Y; Liu Z; Zhou H; Wang H; Zhang W Gene; 2019 Mar; 687():219-227. PubMed ID: 30468907 [TBL] [Abstract][Full Text] [Related]
36. Let-7d Inhibits Growth and Metastasis in Breast Cancer by Targeting Jab1/Cops5. Wei Y; Liu G; Wu B; Yuan Y; Pan Y Cell Physiol Biochem; 2018; 47(5):2126-2135. PubMed ID: 29975923 [TBL] [Abstract][Full Text] [Related]
37. Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu. Hsu MC; Chai CY; Hou MF; Chang HC; Chen WT; Hung WC Mod Pathol; 2008 May; 21(5):609-16. PubMed ID: 18246048 [TBL] [Abstract][Full Text] [Related]
38. Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders. Yang Y; Song R; Gao Y; Yu H; Wang S Mol Med; 2023 Jun; 29(1):80. PubMed ID: 37365502 [TBL] [Abstract][Full Text] [Related]
39. Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair. Tian L; Peng G; Parant JM; Leventaki V; Drakos E; Zhang Q; Parker-Thornburg J; Shackleford TJ; Dai H; Lin SY; Lozano G; Rassidakis GZ; Claret FX Oncogene; 2010 Nov; 29(46):6125-37. PubMed ID: 20802511 [TBL] [Abstract][Full Text] [Related]
40. Jab1 is a specificity factor for E2F1-induced apoptosis. Hallstrom TC; Nevins JR Genes Dev; 2006 Mar; 20(5):613-23. PubMed ID: 16481464 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]